GL · Globe Life Inc.
$171.46
-6.62 (-3.72%)
At close · Aug 19
Market Cap
$13.18B
Shares
76.85M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$171.46
Open$178.08
Day$170.92–178.15
52W close$130.37–186.02
Avg vol 30d638K
Short int1.6M · 2.1% float · 2.1d
Short vol39%
Last earningsJul 23, 2026
DataJan 2020–Aug 2026
Filing10-Q · Aug 5
Up next
Next earnings call
Oct 23, 2026
Est · unconfirmed
· in 9 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 5, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Neutral
Momentum
Strong
Sentiment
Bullish
Fundamentals
Strong
Quant / Vol
Very Low
Market backdrop
VIX 14.9 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+13%
above
Price vs 50-day avg
−3%
below
RSI (14)
36
neutral
MACD trend
Negative
52-week position
74%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−7%
trailing
6-month return
+17%
trailing
YTD return
+23%
this year
Relative strength
+6%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $178 › 200d $152 — 50d above 200d
Institutional flow
Accumulating
+4% holders QoQ · +104 funds added
Insider flow
Distributing
Net -$38.9M over 90 days · 100% sells
Short interest
Falling
2.13% of float · ▼ -9.2% MoM · 2.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
695 holders — near 3-yr high, broad support
Squeeze score
45
elevated · 0–100
Fundamentals
Revenue growth
+4%
Y/Y
Gross margin
21%
expanding
EPS growth
+18%
Y/Y
Free cash flow
$1.3B
Valuation
P/E 11.4
below peers
Balance sheet
$2.3B
net debt
Quant / Vol
risk profile
Volatility
20%
annualized · 1-yr
Max drawdown
−11%
past year
ATR
2.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Jul 22, 2026
Earnings guidance
· full-year 2026
$15.55 – $15.95
Prior guidance
period ended
· from the 8-K filed Oct 22, 2025
Net operating income per diluted common share
· year ending December 31, 2025
$14.40 – $14.60
Guided vs delivered
· last 2 settled
Net operating income per diluted share
year ending December 31, 2023
guided $10.49 – $10.65
$10.07
Miss −4.7%
Net operating earnings per diluted share
full year 2024
guided $11.00 – $11.60
$11.94
Beat +5.7%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+13%
Bullish
Price vs 50-day avg
−3%
Neutral
RSI (14)
36
Neutral
MACD trend
Negative
Bearish
52-week position
74%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $178 › 200d $152 — 50d above 200d
Institutional flow
Accumulating
+4% holders QoQ · +104 funds added
Insider flow
Distributing
Net -$38.9M over 90 days · 100% sells
Short interest
Falling
2.13% of float · ▼ -9.2% MoM · 2.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
695 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $130
Now $171 · 74%
Range high $186
vs 200-day avg +13%
vs 50-day avg -3%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Average annual effective yield | 6.3% | Q2 2026 | — |
|
|
|||
| Average annual effective yield on Fixed Maturity Acquisitions | 6.3% | Quarter Ended June 30, 2026 | — |
| Excess investment income non-GAAP | 38.32M | Three Months Ended June 30, 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net investment income 293.82M
-255.51M Required interest on policy liabilities
= Excess investment income 38.32M
|
|||
| Excess investment income per share non-GAAP | $0.49 | Three Months Ended June 30, 2026 | — |
| Fixed Maturity Acquisitions amount | 399.14M | Quarter Ended June 30, 2026 | — |
| Health Net Sales | 70.4M | Three Months Ended June 30, 2026 | — |
|
|
|||
| Insurance underwriting income non-GAAP | 370.29M | Three Months Ended June 30, 2026 | — |
| Life Net Sales | 149.61M | Three Months Ended June 30, 2026 | — |
| Net income as an ROE | 18.4% | Six Months Ended June 30, 2026 | — |
| Net operating income non-GAAP | 284.69M | Three Months Ended June 30, 2026 | — |
|
|
|||
| Quarterly Average Producing Agent Count at American Income | 11,391 | Quarter Ended June 30, 2026 | — |
| Quarterly Average Producing Agent Count at Family Heritage | 1,608 | Quarter Ended June 30, 2026 | — |
| Quarterly Average Producing Agent Count at Liberty National | 4,194 | Quarter Ended June 30, 2026 | — |
| Shares of Globe Life Inc. common stock repurchased | 1.1M | Three Months Ended June 30, 2026 | — |
|
|
|||
| Average producing agent count increase at Family Heritage Division | 10% | Q1 2026 | — |
| Average producing agent count increase at Liberty National Division | 9% | Q1 2026 | — |
| Book value per share, excluding AOCI non-GAAP | $98.56 | Q1 2026 | — |
GAAP → non-GAAP reconciliationGAAP Book value per share $77.03
+$21.53 Impact of adjustment to exclude AOCI
= Book value per share, excluding AOCI $98.56
|
|||
| Health net sales at United American Division | $62M | Q1 2026 | — |
| Average producing agent count growth | 6% | Q4 2025 | — |
| Health net sales growth | 15% | Q4 2025 | — |
| Life net sales growth | 10% | Q4 2025 | — |
| Net health sales growth | 71% | Q4 2025 | — |
| Net sales of life insurance growth | 11% | Q4 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Insurance - Life — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GL
this stock
Globe Life Inc.
|
$13.18B | +22.6% | +3.7% | 11.4 | 2.1% |
|
CILJF
China Life Insurance Co Ltd
|
$97.80B | +0.4% | — | — | 0.0% |
|
MFC
Manulife Financial Corp
|
$73.51B | +19.7% | — | — | 0.8% |
|
MET
Metlife Inc
|
$61.44B | +20.5% | +8.6% | 18.5 | 1.8% |
|
AFL
Aflac Inc
|
$61.03B | +5.7% | -9.3% | 13.1 | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GL | -3.6% | -6.8% | +17.4% | -5.9% | +22.6% |
| SPY | -0.4% | +2.9% | +11.6% | +3.0% | +12.8% |
| vs SPY | -3.2% | -9.7% | +5.8% | -8.9% | +9.8% |
Capital returns
Latest dividend
$0.33
/ share · ex Jul 6, 2026
Declared · upcoming
$0.33
/ share · ex Oct 5, 2026
Paid (TTM)
$1.20
/ share · 4 payouts
Dividend yield (TTM, derived)
0.70%
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
320335
CUSIP
37959E102
13F (30d)
628 filings
596 filers
Visit website
Investor relations